Since the 2012 approval of shaped implants, their use in breast reconstruction has increased in the United States. However, large-scale comparisons of complications and patient-reported outcomes are lacking. The authors endeavored to compare surgical and patient-reported outcomes across implant types. Methods: The Mastectomy Reconstruction Outcomes Consortium database was queried for expander/implant reconstructions with at least 1-year postexchange follow-up (mean, 18.5 months). Outcomes of interest included postoperative complications, 1-year revisions, and patient-reported outcomes. Bivariate and mixed-effects regression analyses evaluated the effect of implant type on patient outcomes. Results: Overall, 822 patients (73.5 percent) received round and 297 patients (26.5 percent) received shaped implants. Patients undergoing unilateral reconstructions with round implants underwent more contralateral symmetry procedures, including augmentations (round, 18.7 percent; shaped, 6.8 percent; p = 0.003) and reductions (round, 32.2 percent; shaped, 20.5 percent; p = 0.019). Shaped implants were associated with higher rates of infection (shaped, 6.1 percent; round, 2.3 percent; p = 0.002), that remained significant after multivariable adjustment. Other complication rates did not differ significantly between cohorts. Round and shaped implants experienced similar 2-year patient-reported outcome scores. Conclusions: This prospective, multicenter study is the largest evaluating outcomes of shaped versus round implants in breast reconstruction. Although recipients of round implants demonstrated lower infection rates compared with shaped implants, these patients were more likely to undergo contralateral symmetry procedures. Both implant types yielded comparable patient-reported outcome scores. With appropriate patient selection, both shaped and round implants can provide acceptable outcomes in breast reconstruction. (Plast.
S
ince the U.S. Food and Drug Administration's approval of anatomical implants in 2012, 1 there has been increasing adoption of this new technology for breast reconstruction in the United States. [2] [3] [4] Reported benefits of shaped implants include superior lower pole projection and upper pole fill-both features of a more "natural teardrop" appearance. 5, 6 Rupture data from U.S. Food and Drug Administration and European studies also suggest potential improvement in rupture rates, compared with less cohesive gel implants. [7] [8] [9] In theory, the textured surfacing of shaped implants may produce lower Disclosure: Dr. Kim Plastic and Reconstructive Surgery • May 2017 capsular contracture rates compared with the preexisting standard of smooth round implants. 10, 11 These advantages must be weighed against potential problems with firmness, malposition, and malrotation.
Although previous studies have compared outcomes of these two distinct classes of implants in aesthetic breast surgery, few investigators have examined the utility of shaped implants in breast reconstruction. 6, 7, 9, [12] [13] [14] [15] [16] [17] Indeed, the advantages of shaped implants may be greater in breast reconstruction, given the relative paucity of soft-tissue coverage in most mastectomy skin flaps. Compared with breast augmentation, reconstruction presents greater risks of upper pole hollowing and contour rippling. Moreover, with the skin deficits imposed by mastectomy, creation of adequate lower pole projection and maintenance of a natural breast shape present significant additional challenges. 18 With the potential advantages of shaped over smooth round implants, it also remains uncertain whether implant choice impacts the need for contralateral symmetry procedures or subsequent revision procedures.
Use of shaped implants in reconstruction may have potential disadvantages as well. Unlike augmentation, in which the glandular structures remain intact, the relatively greater dead space in the postmastectomy breast may pose a higher risk for implant malposition. With the loss of soft tissue beneath mastectomy skin flaps, the relative firmness and immobility of shaped, textured implants may be additional disadvantages. 19, 20 The texturing of shaped devices may promote biofilm adherence, which may be associated with infection and contracture. 21, 22 Because the relative benefits and risks of shaped implants over round devices have not been well studied in mastectomy reconstruction, new research is needed to evaluate clinical and patient-reported outcomes in this patient populations. Given the increased promotion-and useof shaped implants, we endeavored to evaluate the effects of implant type on outcomes using a multi-institutional, prospective analysis of breast reconstruction.
PATIENTS AND METHODS
The patients included in this analysis were recruited as a part of the Mastectomy Reconstruction Outcomes Consortium Study, a 5-year prospective, multicenter cohort study of mastectomy reconstruction patients, funded by the National Cancer Institute (NCI 1RO1CA152192).
Beginning in February of 2012, women aged 18 years or older, undergoing first-time immediate or delayed breast reconstruction following skin-sparing or nipple-sparing mastectomy, were eligible for inclusion. Reconstructive procedure choice was based on patient and surgeon preferences. The Mastectomy Reconstruction Outcomes Consortium Study collectively included 57 participating plastic surgeons from 11 centers in Michigan, New York, Illinois, Ohio, Massachusetts, Washington, D.C., Georgia, Texas, British Columbia, and Manitoba.
The Mastectomy Reconstruction Outcomes Consortium database was queried retrospectively for all patients who (1) underwent immediate or delayed breast reconstruction using tissueexpander/implant techniques, (2) were past their 24-month postreconstruction assessment time, and (3) had at least 1-year of follow-up after expander-to-implant exchange. One thousand one-hundred nineteen cases were identified. The Mastectomy Reconstruction Outcomes Consortium Study was conducted with appropriate approval from all participating sites' institutional review boards.
Outcomes Variables and Independent Variables
Outcomes of interest included complication rates, operative revisions, and subscale scores from a panel of patient-reported outcomes administered preoperatively and at 24 months postoperatively. Survey instruments included the BREAST-Q 23 and the European Organization for Research and Treatment of Cancer QLQ-BR23. 24 Complication and revision data were collected from electronic medical records at each participating site. Only complications and revision procedures occurring after expander-to-implant exchange and within 24 months of reconstruction were included in this analysis.
The primary predictor variable in the analysis was implant shape. Other independent variables included demographics such as patient age and body mass index. Medical comorbidities were scored by means of the Charlson index. 25 In addition, data were gathered on clinical variables such as implant material and volume, laterality, indications for mastectomy (i.e., therapeutic or prophylactic), lymph node management, use of acellular dermal matrix, radiation therapy, and chemotherapy. For the comparison of both complications and patient-reported outcomes, the analyses also controlled for a patient's duration of follow-up (i.e., the number of months between expander exchange and 24 months).
Statistical Analysis
Descriptive statistics for relevant baseline characteristics were calculated for the shaped and round implant cohorts. Bivariate analyses, including Pearson's chi-square tests for categorical variables and t tests for continuous variables, identified significant differences in baseline characteristics between the cohorts. Unadjusted comparisons of complication rates and patient-reported outcomes between the two cohorts were made using logistic and linear regression models, respectively, with implant shape as a single predictor. For both logistic and linear regressions, mixed-effects models with sites as random intercepts were used to adjust for potential within-site correlation of outcomes. For covariate-adjusted comparisons of complications and patient-reported outcomes at 2 years, the respective regression models were adjusted for baseline characteristics that were potential confounders or known to be associated with the outcomes. All statistical analyses were performed with SAS 9.4 (SAS Institute, Inc., Cary, N.C.), and statistical significance was set at 0.05.
RESULTS

Demographic and Clinical Characteristics
In total, 1119 patients met our inclusion criteria, including 822 (73.5 percent) who underwent breast reconstruction with round implants and 297 (26.5 percent) who underwent breast reconstruction with shaped implants. Demographic and clinical variables, and bivariate analyses, are summarized in Table 1 . Differences between the study cohorts were observed for a number of the variables, with patients with round implants having a higher body mass index (p = 0.004) and lower Charlson index (p = 0.032) than patients receiving shaped implants. Moreover, patients with round implants were significantly more likely to have Plastic and Reconstructive Surgery • May 2017 mastectomies for prophylaxis (p = 0.040) and use acellular dermal matrix (p < 0.001). In contrast, the shaped implant cohort had a higher likelihood of having had radiation therapy (p = 0.002) compared with women who received round implants. A significantly higher mean volume was observed for the round implant cohort, compared with that of the shaped implant group (p < 0.001).
Revisions and Symmetry Procedures
Revision rates are summarized in Figure 1 . At a mean 18.5 months' follow-up, 29.1 percent of the round implant cohort had undergone operative revisions compared with 21.9 percent of the shaped implant cohort (p = 0.129). The most common individual revision procedures were fat grafting (round, 16.9 percent; shaped, 12.5 percent; p = 0.097) and explantation (round, 9.9 percent; shaped, 10.8 percent; p = 0.365). Capsulotomy/ capsulectomy, recontouring/repositioning, and scar revision/dog-ear excision rates did not differ significantly between cohorts.
Analysis of contralateral symmetry procedures in 390 patients with unilateral reconstructions (Table 2) showed the round implant cohort to be more likely than the shaped implant cohort to receive a contralateral breast reduction (round, 18.7 percent; shaped, 6.8 percent; p = 0.003) or augmentation (round, 32.2 percent; shaped, 20.5 percent; p = 0.019).
Complications
Bivariate analysis results are summarized in Table 3 .
Rates for other complications, including seroma, hematoma, mastectomy flap necrosis, implant malposition, capsular contracture, and implant rupture, did not differ significantly between cohorts. Regression analyses (Table 4) identified shaped implant to be an independent risk factor for any complication (OR, 1.83) and major complications (OR, 2.81). 
Patient-Reported Outcomes
Baseline and 2-year postoperative patientreported outcome scores for the BREAST-Q and European Organization for Research and Treatment of Cancer QLQ-BR23 are presented in Table 5 . Survey data were available for 1087 patients, including 803 with round and 284 with shaped implants. In the multivariate regressions, implant shape had no significant effects on any of the BREAST-Q or European Organization for Research and Treatment of Cancer QLQ-BR23 subscales (Table 6 ).
DISCUSSION
In recent years, implant choices have evolved to include both shaped and round forms. Despite widespread use of implant-based breast reconstruction, few direct comparisons of implant types exist.
Longitudinal postmarket studies from implant manufacturers have outlined complication rates such as reoperation, explantation, and infection; however, in-depth assessments of risk factors and 
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comorbidities are often not performed in these analyses. 15 Other well-designed studies that have compared patient-reported outcomes between shaped and round implants have been limited by small sample sizes. 7 The Mastectomy Reconstruction Outcomes Consortium Study is well suited to perform analyses of different implant types because of its prospective, multicenter design, and its inclusion of risk factors, surgical outcomes, and patient-reported outcomes.
In our analysis, demographic and clinical differences existed between the two cohorts (Table 1 )-most notably, with a higher percentage of shaped implants having associated radiation therapy. Given that radiation creates tighter, thinner mastectomy flaps, shaped implants-by virtue of their firmer, more projecting design and improved structural reach into the upper polemay provide an advantage over their round, softer gel counterparts. The increased use of shaped implants in these patients may reflect this putative benefit. Furthermore, the finding that the round implant cohort had a higher body mass index and greater implant volume may be an artifact of the limited availability of higher volume shaped implants.
With the exception of surgical-site infection requiring intravenous antibiotics, individual complication rates did not differ significantly between the shaped and round implant cohorts. Although our infection rates are generally low and in alignment with the literature, the rate of infections requiring intravenous antibiotics was higher within the shaped cohort (4.0 percent) compared with the round cohort (0.1 percent; p = 0.001). This difference is potentially attributable to the higher rates of postmastectomy irradiation in the shaped implant cohort (Table 1) , but further multivariable analyses adjusting for radiation therapy and other baseline covariates could not be performed because of the small number of infections requiring intravenous antibiotics. The incidences of other early complications such as seroma, hematoma, wound dehiscence, and explantation were similar in the two groups. Our follow-up, however, is insufficient to fully address late complications such as implant malposition, rupture, and capsular contracture. Although the low rates of these complications in this series are consistent with other short-term reports in the literature, previous manufacturer data show an increase in the malposition rate to 5 to 6 percent at 8 to 10 years. 5, 6, 12 Additional studies will be necessary to bear out any significant impact of implant shape on these outcomes. The variation in surgical-site infection rates between our cohorts appears to drive the overall difference observed in major and overall complication rates. Mixed-effects logistic regression models confirmed these differences between the two cohorts after controlling for potential confounding. Although the underlying causes for these differences are uncertain, they may be attributable to the textured surfacing of shaped implants, with the potential for greater bacterial adherence and subsequent biofilm formation. 21, 22 Unilateral reconstructions with round implants underwent more contralateral symmetry procedures, including augmentation (round, 32.2 percent; shaped, 20.5 percent; p = 0.019) and reduction (round, 18.7 percent; shaped, 6.8 percent; p = 0.003) for symmetry ( Table 2 ). The benefit of shaped implants may be in their more natural shape, and this may account for the decreased need for contralateral symmetry procedures.
In our study population, roughly one in four patients underwent revision of their breast reconstruction (Fig. 1) . Although lower than the 45 to 55 percent long-term revision rates noted in core studies of longer duration, 5, 6, 12, 26 these results are consistent with other 1-and 2-year analyses. 6 Although not statistically significant, higher rates of revision procedures were seen with round versus shaped implants (29.1 percent versus 21.9 percent, respectively; p = 0.129)-attributable largely to higher use of fat grafting. Two common indications for fat grafting in prosthetic breast reconstruction are upper pole hollowing and rippling. 7, 27, 28 Because shaped implants have a structural extension into the upper pole, resulting in a less abrupt transition, and are less prone to rippling because of their firmer composition, patients with this type of implant may require fat grafting less frequently.
With over 1100 patients, our analysis is the largest to date to compare patient-reported outcomes between shaped and round implants. Moreover, the response rate to the patient-reported outcome surveys was generally robust at 65 percent-above the 60 percent threshold generally agreed on as acceptable for clinical research. [29] [30] [31] Overall, patient-reported outcome scores did not differ between the implant types, which is congruent with earlier, smaller comparative studies. 7 However, patients in the shaped implant cohort reported higher well-being and satisfaction scores before surgery.
As always, there were limitations to our study. Because implant selection was nonrandom, preexisting patient or surgeon factors may have accounted for cohort differences (or lack thereof). For example, the two cohorts may not have differed with regard to satisfaction simply because each patient received the implant that specifically suited their clinical presentation. Without a randomized design, there was a potential for selection bias-patients with greater tightness or contour deformity may have been preferentially selected for shaped implants, to improve lower pole projection and overall contour. Moreover, the effects of implant type on patient-reported outcomes may have been confounded by revision procedures. The impact of surgeon experience and steeper learning curves with the newer shaped implant technology could also have produced differences in complication rates between the implant types. For the complications that typically manifest at later time points-contracture and rupture-our follow-up period is not sufficient to evaluate real differences. Although use of a randomized clinical trial design would have addressed many of these potential limitations, this approach would be logistically difficult, given the strong surgeon and patient preferences inherent in clinical decision-making for breast reconstruction.
CONCLUSIONS
There is a paucity of research investigating the impact of implant types on breast reconstruction outcomes. This prospective, multicenter analysis is the largest to date evaluating outcomes of round versus shaped implants. In our analysis, round implants were associated with lower rates of infection compared with shaped devices. However, shaped implants appeared to require fewer contralateral symmetry procedures than their round counterparts. Ultimately, both devices yielded comparable patient-reported satisfaction at 2 years after reconstruction. With appropriate patient selection, both implant types can provide acceptable outcomes for breast reconstruction patients.
